Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11491222
Method of treating lower back pain
granted -
US 11491212
Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B
granted -
US 11491125
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
granted -
US 11491187
Methods of conditioning patients for T cell therapy
granted -
US 11491145
Combination therapies comprising targeted therapeutics
granted -
US 11491115
Nanoparticles containing extracellular matrix for drug delivery
granted -
US 11491111
Thermostable vaccine compositions and methods of preparing same
granted -
US 11490643
Lactobacillus casei for treating obesity and associated metabolic disorders
granted -
US 11491193
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11492604
Transposase polypeptides and uses thereof
granted -
US 11492388
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
granted -
US 11492643
Methods and compositions for treatment of a genetic condition
granted -
US 11491238
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 11491190
Visco-supplement compositions, and methods of use thereof
granted -
WO 2022229817
VACCINS COMPRENANT DES PARTICULES PSEUDO-VIRALES PRÉSENTANT DES ANTIGÈNES DU SARS-COV-2 ET LEURS MÉTHODES D'UTILISATION
granted -
US 2022348923
CA-IX APTAMERS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
granted -
IT 202100010802
FORMULAZIONE SOLIDA MUCOADESIVA COMPRENDENTE PROBIOTICI PER USO NELLA PREVENZIONE E NEL TRATTAMENTO DI DISBIOSI ORALE.
granted -
US 11485760
Inhibitors of CRISPR-Cas9
granted -
US 11484602
Bicyclic peptide ligands specific for EphA2
granted -
US 11484477
Dental adhesive material kit
granted -
US 11485958
HSD17B13 variants and uses thereof
granted -
US 11484523
Compositions for prevention and treatment of symptoms associated with alcohol consumption
granted -
US 11484521
Antidotes to cyanide poisoning
granted -
US 11484511
Pharmaceutical composition comprising THA as effective ingredient for treatment of prostate cancer
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.